| ￥1200 | |
| A03954 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to MAD2L2 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human MAD2L2 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||||
|
|||||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Target Background | Adapter protein able to interact with different proteins and involved in different biological processe.Mediates the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1, thereby mediating the second polymerase switching in translesion DNA synthesis. |
| Synonyms | hREV7; MAD2B; Mad2l2 Mitotic Arrest Deficient 2 L2; POLZ2; REV 7; REV7; REV7 homolog; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
